CONSENT, ASSUMPTION AND SECOND LOAN MODIFICATION AGREEMENTConsent, Assumption and Second Loan Modification Agreement • May 15th, 2009 • Pharmathene, Inc • Pharmaceutical preparations
This Consent, Assumption and Second Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of March 31, 2009, by and among SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at 8020 Tower Crescent Drive, Suite 475, Vienna, Virginia 22182 (“SVB”), as agent (“Agent”), and the Lenders, SVB and OXFORD FINANCE CORPORATION (“Oxford”), and PHARMATHENE, INC. (“New Borrower”) (successor by merger with Pharmathene U.S. Corporation, a Delaware corporation, the “Existing Borrower”), a Delaware corporation with its chief executive office located at One Park Place, Suite #450, Annapolis, MD 21401.
